WordNet

prepare or position for action or operation; "lay a fire"; "lay the foundation for a new health care plan"
put in a horizontal position; "lay the books on the table"; "lay the patient carefully onto the bed" (同)put down, repose
impose as a duty, burden, or punishment; "lay a responsibility on someone"
lay eggs; "This hen doesnt lay"
not of or from a profession; "a lay opinion as to the cause of the disease"
make or form a layer; "layer the different colored sands"
single thickness of usually some homogeneous substance; "slices of hard-boiled egg on a bed of spinach" (同)bed
a hen that lays eggs
thin structure composed of a single thickness of cells
a relatively thin sheetlike expanse or region lying over or under another
acquire pigment; become colored or imbued
any substance whose presence in plant or animal tissues produces a characteristic color
color or dye with a pigment; "pigment a photograph"
dry coloring material (especially a powder to be mixed with a liquid to produce paint, etc.)
of or belonging to the epithelium; "epithelial layer"
with one layer on top of another; "superimposed rocks" (同)superimposed

PrepTutorEJDIC

《場所の副詞[句]を伴って》‘を'『置く』,横たえる / ‘を'『きちんと置く』(並べる),〈土台など〉‘を'すえる,〈鉄道など〉‘を'敷設する / …‘を'『用意する』,準備する / (…に)〈身体の一部〉‘を'置く,つける《+『名』+『on』(『to』)+『名』》 / (…に)〈信頼・愛情〉‘を'置く,寄せる,託す;〈強調・重要性など〉‘を'置く《+『名』+『on』+『名』》 / 〈ほこり・波・風など〉‘を'押さえる,〈恐れ亡霊など〉‘を'静める,なだめる / 〈卵〉‘を'産む / 〈かけ〉‘を'する;(…に)〈金〉‘を'かける《+『名』+『on』+『名』》 / (…に)〈税・罰金・義務など〉‘を'課する,〈重荷・責任など〉‘を'負わせる《+『名』+『on』(『upon』)+『名』》 / 〈悪事など〉‘を'(…の)せいにする《+『名』+『against』(『to』)+『名』》 / 《状態を表す副詩[句]を伴って》(特によくない状態に)…‘を'『置く』,する / (…に)〈権利の主張・報告など〉‘を'提出する,申し出る《+『名』+『before』(『to』)+『名』》 / (…で)…‘の'表面をおおう《+『名』+『with』+『名』》;(…に)…‘を'広げる《+『名』+『on』+『名』》 / 卵を産む / 位置,配置,地形,地勢
lieの過去形
(歌うために書かれた)短い物語詩 / 《詩》(一般に)歌,調べ
(僧職にある人に対して)俗人の / (専門家に対して)しろうとの,門外漢の
《複合語を作って》(物を)積む人(物),置く人(物) / 卵を産む鶏・層;(ペンキなどの)一塗り;一皮 / (園芸で)取り木 / …‘を'層にする / 〈植物〉‘を'取り木する
〈U〉〈C〉(おもに紛末の)絵の具,顔料 / 〈U〉色素

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 上皮性卵巣癌、卵管癌、および腹膜癌：臨床的特徴および診断 epithelial carcinoma of the ovary fallopian tube and peritoneum clinical features and diagnosis
2. レーザー屈折矯正手術 laser refractive surgery
3. 糸球体半月体形成の機序 mechanisms of glomerular crescent formation
4. 単純ヘルペス性角膜炎 herpes simplex keratitis
5. ダーモスコピーによる皮膚癌の治療優先順位決定のアルゴリズム dermoscopic algorithms for skin cancer triage

English Journal

Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line.

Karakoçak BB1, Raliya R2, Davis JT3, Chavalmane S2, Wang WN4, Ravi N5, Biswas P6.
Toxicology in vitro : an international journal published in association with BIBRA.Toxicol In Vitro.2016 Dec;37:61-69. doi: 10.1016/j.tiv.2016.08.013. Epub 2016 Sep 4.
Gold nanoparticles (Au NPs) have been tested as targeted delivery agents because of their high chemical stability and surface plasmon properties. Here, we investigated the biocompatibility of Au spheres (5-, 10-, 20-, 30-, 50-. and 100-nm), cubes (50-nm), and rods (10×90nm) on a retinal pigment epi
PMID 27599945

Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments.

Balaratnasingam C1, Yannuzzi LA2, Curcio CA3, Morgan WH4, Querques G5, Capuano V6, Souied E5, Jung J7, Freund KB8.
Investigative ophthalmology & visual science.Invest Ophthalmol Vis Sci.2016 Oct 1;57(13):5479-5489. doi: 10.1167/iovs.16-19816.
Purpose: Drusenoid pigment epithelial detachments (PEDs) are a defined path to atrophy in age-related macular degeneration (AMD). We analyzed the relationships between retinal pigment epithelium (RPE) and drusen volume changes during the PED lifecycle, using spectral-domain optical coherence tomogra
PMID 27760262

AN UPDATED STAGING SYSTEM OF TYPE 3 NEOVASCULARIZATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.

Su D1, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, Sarraf D.
Retina (Philadelphia, Pa.).Retina.2016 Aug 29. [Epub ahead of print]
PURPOSE: To comprehensively investigate spectral domain optical coherence tomography features associated with Type 3 neovascularization and determine the prevalence of each feature and to develop an updated staging system for Type 3 neovascularization based on spectral domain optical coherence tomog
PMID 27575412